NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-184-2016-1-IL-09 Targeted Combination Therapy IL National Stage 269986 Issued
NHGRI E-175-2019-0-US-01 Synthetic Genes For The Treatment Propionic Acidemia (PA) Caused By Mutations In Propionyl-coA Carboxylase Alpha (PCCB) US 62/915,347 Abandoned
NCATS E-022-2018-0-JP-07 COMPOSITIONS AND METHODS FOR CELL CULTURE JP National Stage 2021-520118 Issued
NIA E-139-2012-2-US-14 METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES US CON 16/600,234 10772849 Issued PDF
NCATS E-022-2018-0-PCT-02 COMPOSITIONS AND METHODS FOR CELL CULTURE PCT PCT PCT/US2019/055940 Expired
NCATS E-022-2018-0-EP-06 COMPOSITIONS AND METHODS FOR CELL CULTURE EP National Stage 19797474.4 Pending
NCI E-184-2016-1-JP-10 Targeted Combination Therapy JP National Stage 2019-555879 Pending
NCATS E-022-2018-0-CA-05 COMPOSITIONS AND METHODS FOR CELL CULTURE CA National Stage 3116212 Pending
NCATS E-022-2018-0-AU-04 COMPOSITIONS AND METHODS FOR CELL CULTURE AU National Stage 2019359473 Pending
NCI E-174-2019-0-US-01 A VIRAL EXPOSURE SIGNATURE FOR DETECTION OF EARLY STAGE HEPATOCELLULAR CARCINOMA US 62/914,138 Abandoned
NCI E-106-2014-0-TW-18 YEAST-BASED IMMUNOTHERAPY FOR CHORDOMA TW DIV 108107386 Pending
NCI E-344-2013-0-ES-01 TEM8 ANTIBODIES AND THEIR USE ES EP 19201975.0 Issued
NCI E-344-2013-0-DE-01 TEM8 ANTIBODIES AND THEIR USE DE EP 19201975.0 Issued
NCI E-344-2013-0-IT-01 TEM8 ANTIBODIES AND THEIR USE IT EP 19201975.0 Issued
NCI E-344-2013-0-FR-01 TEM8 ANTIBODIES AND THEIR USE FR EP 19201975.0 Issued
NCI E-344-2013-0-EP-11 TEM8 ANTIBODIES AND THEIR USE EP DIV 19201975.0 Issued
NIAID E-357-2001-1-US-33 CONSTRUCTION OF WEST NILE VIRUS AND DENGUE VIRUS CHIMERAS FOR USE IN A LIVE VIRUS VACCINE TO PREVENT DISEASE CAUSED BY WEST NILE VIRUS US DIV 16/596,175 10869920 Expired PDF
NCI E-176-2015-1-US-02 COMPOSITIONS AND METHODS FOR THE DETECTION AND TREATMENT OF CERVICAL CANCER AND CERVICAL INTRAEPITHELIAL NEOPLASIA US CON 16/595,564 Pending
NIAID E-066-2020-0-EP-02 Improvement Of Trispecific Antibodies To HIV-1 By Engraftment Of The FR3 Loop Of VRC03 (FR3-03) EP ORD 19306312.0 Pending
NIAAA E-258-2012-0-US-02 Ketone Bodies To Protect Tissues From Damage By Ionizing Radiation US CON 16/594,431 11234953 Issued PDF
NIA E-051-2008-0-US-03 PLASMA CELL CYTOKINE VEHICLE CONTAINING FUSION PROTEINS FOR TARGETED INTRODUCTION OF SIRNA INTO CELLS AND TISSUES US CIP 16/594,864 Abandoned
NIAID E-137-2018-2-IL-09 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response IL National Stage 269830 Issued
NICHD E-093-2017-0-US-03 ISOTROPIC GENERALIZED DIFFUSION TENSOR MRI US National Stage 16/603,205 11835611 Issued PDF
NCI E-035-2017-0-US-17 STAT3 INHIBITOR FORMULATION US National Stage 16/603,110 10913709 Abandoned PDF
NCATS E-130-2017-0-US-03 Target JAK2/IL11-mediated Pathway By LY2784544 To Treat Platinum Drug Resistant Ovarian Cancer US National Stage 16/500,959 Abandoned
NIAID E-137-2018-2-US-02 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response US National Stage 16/500,762 12370255 Issued PDF
NCI E-067-2017-0-AU-03 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES AU National Stage 2018244371 Issued
NCI E-277-2016-0-US-03 FUNCTIONALLY-INTERDEPENDENT SHAPE SWITCHING NUCLEIC ACID NANOPARTICLES US National Stage 16/500,765 11512313 Issued PDF
NCI E-229-2014-0-JP-08 METHODS FOR ISOLATING T CELLS HAVING ANTIGEN SPECIFICITY TO CANCER SPECIFIC MUTATIONS JP DIV 2019-182421 Issued
NIAID E-213-2021-2-PCT-01 Aromatic Ring Substituted Amphiphilic Polymers As Drug Delivery Systems PCT PCT COMB PCT/US2019/054343 Expired
NIAID E-213-2021-2-EP-04 Aromatic Ring Substituted Amphiphilic Polymers As Drug Delivery Systems EP National Stage 19798423.0 Abandoned
NIAID E-213-2021-2-CA-03 Aromatic Ring Substituted Amphiphilic Polymers As Drug Delivery Systems CA National Stage 3113782 Pending
NIAID E-213-2021-2-AU-02 Aromatic Ring Substituted Amphiphilic Polymers As Drug Delivery Systems AU National Stage 2019355926 Pending
NCI E-114-2020-0-US-01 Methods and Compositions For Promoting An Immune Response and For Combination Therapy US 62/908,759 Abandoned
NCI E-008-2019-0-CN-08 IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF CN National Stage 201980078691.8 Issued
NCI E-008-2019-0-AU-03 IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF AU National Stage 2019347873 Issued
NCI E-067-2017-0-IT-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES IT EP 18721882.1 Issued
NCI E-067-2017-0-FR-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES FR EP 18721882.1 Issued
NCI E-067-2017-0-SE-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES SE EP 18721882.1 Issued
NCI E-067-2017-0-CH-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES CH EP 18721882.1 Issued
NCI E-067-2017-0-ES-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES ES EP 18721882.1 Issued
NCI E-067-2017-0-NL-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES NL EP 18721882.1 Issued
NCI E-067-2017-0-DE-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES DE EP 18721882.1 Issued
NCI E-067-2017-0-EP-06 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES EP National Stage 18721882.1 Issued
NCI E-067-2017-0-GB-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES GB EP 18721882.1 Issued
NCI E-116-2017-0-US-03 Human Antibodies Against CD33 US DIV 16/588,357 11464801 Issued PDF
NCI E-038-2018-0-US-04 Compositions and Methods for Treating Cancer with Anti-ROR1 Immunotherapy US DIV 16/588,591 11453719 Issued PDF
CC E-032-2020-0-US-01 SPECTRAL CT-BASED 511 KEV FOR POSITRON EMISSION
TOMOGRAPHY 		US ORD 16/587,789 11389127 Issued PDF
NCI E-008-2019-0-PCT-02 IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF PCT PCT PCT/US2019/053825 Expired
NCI E-008-2019-0-EP-06 IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF EP National Stage 19865927.8 Pending